Home
Clinical Resources Search
PQI: Management of Abemaciclib (Verzenio®) Associated Diarrhea

Management of Abemaciclib (Verzenio®) Associated Diarrhea

Download PQI pdf 0.16MB

Last Updated: March 15, 2024

By: Derek Gyori, PharmD | Julianne Darling, PharmD

About this PQI

Abemaciclib is FDA-approved in combination with an aromatase inhibitor, fulvestrant, and as a single agent in early high-risk, advanced, or metastatic breast cancer. This PQI will address effective practices for the management of abemaciclib associated diarrhea, a common toxicity with this therapy.

More About This PQI

PQI:

Advanced-Breast-Cancer-Appropriate-Patient-Identification-with-Abemaciclib-Verzenio_PQI_NCODA pdf 0.14MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Diarrhea Abemaciclib Verzenio

PQI

Frequently Searched

Supported by

Management of Abemaciclib (Verzenio®) Associated Diarrhea

About this PQI

More About This PQI

PQI:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Telotristat Ethyl (Xermelo®) for the Management of Carcinoid Syndrome Diarrhea

PQI: Oncolytic Induced Diarrhea

PQI in Action: Telotristat Ethyl: Carcinoid Syndrome Diarrhea

Treatment Support Kit: Abemaciclib

PQI: CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer

PQI: Advanced Breast Cancer: Appropriate Patient Identification with Abemaciclib (Verzenio®)

Treatment Support Kit: Abemaciclib

PQI: CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer

PQI: Advanced Breast Cancer: Appropriate Patient Identification with Abemaciclib (Verzenio®)

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting